Pemphigus foliaceus and pemphigus erythematosus

Christoph M. Hammers; Enno Schmidt; Luca Borradori

doi:10.1007/978-3-662-45139-7_69

Pemphigus foliaceus and pemphigus erythematosus

Christoph M. Hammers, Enno Schmidt^*, Luca Borradori

^*Corresponding author for this work

University of Bern

Abstract

Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

Original language	English
Title of host publication	European Handbook of Dermatological Treatments, Third Edition
Number of pages	10
Publisher	Springer Berlin Heidelberg
Publication date	01.01.2015
Pages	691-700
ISBN (Print)	9783662451380
ISBN (Electronic)	9783662451397
DOIs	https://doi.org/10.1007/978-3-662-45139-7_69
Publication status	Published - 01.01.2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1007/978-3-662-45139-7_69

Cite this

@inbook{e0f921008c464bac86c669a052fa750d,

title = "Pemphigus foliaceus and pemphigus erythematosus",

abstract = "Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.",

author = "Hammers, \{Christoph M.\} and Enno Schmidt and Luca Borradori",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Berlin Heidelberg 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-45139-7\_69",

language = "English",

isbn = "9783662451380",

pages = "691--700",

booktitle = "European Handbook of Dermatological Treatments, Third Edition",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Pemphigus foliaceus and pemphigus erythematosus

AU - Hammers, Christoph M.

AU - Schmidt, Enno

AU - Borradori, Luca

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

AB - Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

UR - https://www.scopus.com/pages/publications/84944566860

U2 - 10.1007/978-3-662-45139-7_69

DO - 10.1007/978-3-662-45139-7_69

M3 - Chapter

AN - SCOPUS:84944566860

SN - 9783662451380

SP - 691

EP - 700

BT - European Handbook of Dermatological Treatments, Third Edition

PB - Springer Berlin Heidelberg

ER -

Pemphigus foliaceus and pemphigus erythematosus

Abstract

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Fingerprint

Cite this